Russell J. Cox Insider Trading $JAZZ Jazz Pharmaceuticals plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Russell J. Cox.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Russell J. Cox. Russell J. Cox is EVP & Chief Commercial Officer in Jazz Pharmaceuticals plc ($JAZZ) and EVP & COO in Jazz Pharmaceuticals plc ($JAZZ) and SVP, Sales and Marketing in Jazz Pharmaceuticals plc ($JAZZ) and Chief Executive Officer in VITAL THERAPIES INC ($VTL) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and Director in Gossamer Bio, Inc. ($GOSS).
Russell J. Cox in Jazz Pharmaceuticals plc
Trading Symbol: JAZZIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Russell J. Cox: EVP & Chief Commercial Officer, EVP & COO, SVP, Sales and Marketing
Holdings: 96,263 shares
Current Value: $12,037,688
Latest Transaction: Dec 13 2017
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Russell J. Cox in Jazz Pharmaceuticals plc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGLE, GOSS, VTL, JAZZ
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | M | 59.13 | 1,691 | 99,989 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | M | 46.83 | 4,867 | 227,922 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | M | 8.23 | 44,200 | 363,766 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Buy | M | 59.13 | 1,691 | 99,989 | 102,821 | 101.1 K to 102.8 K (+1.67 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Buy | M | 46.83 | 4,867 | 227,922 | 101,130 | 96.3 K to 101.1 K (+5.06 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Buy | M | 8.23 | 44,200 | 363,766 | 96,263 | 52.1 K to 96.3 K (+84.90 %) |
Aug 09 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 155.56 | 978 | 152,138 | 51,985 | 53 K to 52 K (-1.85 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 132.81 | 1,793 | 238,128 | 52,795 | 54.6 K to 52.8 K (-3.28 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 136.18 | 24,266 | 3,304,544 | 24,266 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 136.18 | 734 | 99,956 | 734 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Grant | A | 0.00 | 10,000 | 0 | 54,588 | 44.6 K to 54.6 K (+22.43 %) |
Jan 19 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 130.00 | 3,000 | 390,000 | 47,095 | 50.1 K to 47.1 K (-5.99 %) |
Jan 19 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 125.00 | 1,000 | 125,000 | 50,095 | 51.1 K to 50.1 K (-1.96 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 148.66 | 4,000 | 594,640 | 51,038 | 55 K to 51 K (-7.27 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 150.01 | 4,565 | 684,796 | 55,038 | 59.6 K to 55 K (-7.66 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 148.66 | 4,000 | 594,640 | 51,038 | 55 K to 51 K (-7.27 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 149.02 | 978 | 145,742 | 59,603 | 60.6 K to 59.6 K (-1.61 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 150.01 | 4,565 | 684,796 | 55,038 | 59.6 K to 55 K (-7.66 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 149.02 | 978 | 145,742 | 59,603 | 60.6 K to 59.6 K (-1.61 %) |
Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 127.84 | 1,550 | 198,152 | 64,470 | 66 K to 64.5 K (-2.35 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 121.58 | 939 | 114,164 | 66,020 | 67 K to 66 K (-1.40 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 123.36 | 21,689 | 2,675,555 | 21,689 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 123.36 | 811 | 100,045 | 811 | |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 125.00 | 731 | 91,375 | 66,959 | 67.7 K to 67 K (-1.08 %) |
Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Grant | A | 0.00 | 9,000 | 0 | 67,690 | 58.7 K to 67.7 K (+15.33 %) |
Apr 13 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 136.98 | 4,000 | 547,920 | 60,470 | 64.5 K to 60.5 K (-6.20 %) |
Aug 12 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Sell | S | 177.82 | 500 | 88,910 | 58,602 | 59.1 K to 58.6 K (-0.85 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Payment of Exercise | F | 181.48 | 4,565 | 828,456 | 59,102 | 63.7 K to 59.1 K (-7.17 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Payment of Exercise | F | 181.79 | 978 | 177,791 | 63,667 | 64.6 K to 63.7 K (-1.51 %) |
Apr 16 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 181.45 | 500 | 90,725 | 64,553 | 65.1 K to 64.6 K (-0.77 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 175.10 | 500 | 87,550 | 65,053 | 65.6 K to 65.1 K (-0.76 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 174.76 | 1,571 | 274,548 | 65,553 | 67.1 K to 65.6 K (-2.34 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 175.19 | 19,430 | 3,403,942 | 19,430 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 175.19 | 570 | 99,858 | 570 | |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 170.09 | 948 | 161,245 | 67,124 | 68.1 K to 67.1 K (-1.39 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Grant | A | 0.00 | 7,675 | 0 | 68,072 | 60.4 K to 68.1 K (+12.71 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Option Exercise | D | 8.23 | 45,200 | 371,996 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Sell | D | 0.00 | 19,005 | 0 | 0 | 19 K to 0 (-100.00 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Option Exercise | M | 27.46 | 40,000 | 1,098,400 | 0 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Option Exercise | M | 8.23 | 14,800 | 121,804 | 45,200 | |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Payment of Exercise | F | 48.60 | 29,083 | 1,413,434 | 19,005 | 48.1 K to 19 K (-60.48 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Buy | M | 27.46 | 40,000 | 1,098,400 | 48,088 | 8.1 K to 48.1 K (+494.56 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Payment of Exercise | F | 48.60 | 7,927 | 385,252 | 8,088 | 16 K to 8.1 K (-49.50 %) |
Jan 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Buy | M | 8.23 | 14,800 | 121,804 | 16,015 | 1.2 K to 16 K (+1,218.11 %) |
Dec 02 2011 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Buy | J | 14.89 | 1,007 | 14,994 | 1,215 | 208 to 1.2 K (+484.13 %) |
Jun 02 2011 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Buy | J | 14.89 | 208 | 3,097 | 208 | 0 to 208 |
Mar 11 2011 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Option Exercise | A | 27.46 | 40,000 | 1,098,400 | 40,000 |
Page: 1